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Background: Fatty acid binding protein 4 (FABP4, also designated as adipocyte-FABP or aP2) has been described to be most exclusively expressed 
in adipocytes and macrophages. Circulating FABP4 levels have been linked to metabolic alternations that are associated adiposity. We have 
recently reported that FABP4 is abundantly expressed in capillary endothelial cells of heart and skeletal muscle. In the present study, we tested the 
hypothesis that FABP4 levels are elevated in patients with acute myocardial infarction (AMI) and compared the time-dependent change of FABP4 
levels with that of high sensitive troponinT (hsTnT) levels in AMI patients.
methods: and Results; Biochemical markers including FABP4 were measured in 22 patients with AMI who underwent primary coronary intervention 
and 22 with stable effort angina pectoris (stable AP). Time-dependent changes in FABP4 and hsTnT levels were analyzed in AMI patients. Serum 
FABP4 levels were significantly higher in AMI than stable AP. In AMI patients, FABP4 levels were correlated with hsTnT levels on immediately after PCI 
(R2=0.643, p=0.009). In contrast, in samples on admission, FABP4 levels were not correlated with hsTnT levels. Furthermore, time to peak of FABP4 
level was earlier than that of hsTnT.
conclusion: Circulating FABP4 levels were elevated before the elevation of cardiac TnT levels, suggesting that FABP4 appears to be a useful marker 
for earlier stage of AMI. These data are consistent with our hypothesis that FABP4 is released from capillary endothelium that might be damaged 
earlier than myocardium in AMI patients.
